Pacing in hypertrophic obstructive cardiomyopathy: First choice therapy in low volume centers?

Hypertrophic cardiomyopathy (HCM) is a very intriguing heritable disease, definied as left ventricular hypertrophy in the absence of a secondary cause. The heterogenity in phenotypic expression makes treatment of patients very challenging. Fortunately, most patients have a benign prognosis, however in a subset of patients the clinical outcome is less favourable as patients present with symptoms of congestive heart failure or sudden cardiac death [1]. Symptoms are often related to left ventricular outflow tract (LVOT) obstruction.

Source: International Journal of Cardiology - October 8, 2020 Category: Cardiology Authors: Marcel J.M. Kofflard Tags: Editorial Source Type: research